These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30285798)

  • 1. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.
    Ling X; Wu W; Fan C; Xu C; Liao J; Rich LJ; Huang RY; Repasky EA; Wang X; Li F
    J Exp Clin Cancer Res; 2018 Oct; 37(1):240. PubMed ID: 30285798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
    Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
    PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
    Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
    Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
    Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
    Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, is highly dependent on its primary structure and steric configuration.
    Zhao J; Ling X; Cao S; Liu X; Wan S; Jiang T; Li F
    Mol Pharm; 2014 Feb; 11(2):457-67. PubMed ID: 24329001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and In Vitro/In Vivo Anti-Cancer Activities of Novel (20
    Dai X; Wu G; Zhang Y; Zhang X; Yin R; Qi X; Li J; Jiang T
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer.
    Tang Z; Ji L; Han M; Xie J; Zhong F; Zhang X; Su Q; Yang Z; Liu Z; Gao H; Jiang G
    Life Sci; 2020 Sep; 257():118065. PubMed ID: 32659366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?
    Li F
    Am J Cancer Res; 2014; 4(3):304-11. PubMed ID: 24959385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
    Li F; Ling X; Harris DL; Liao J; Wang Y; Westover D; Jiang G; Xu B; Boland PM; Jin C
    Am J Cancer Res; 2017; 7(2):370-382. PubMed ID: 28337384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis.
    Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G
    Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity.
    Wang W; Ling X; Wang R; Xiong H; Hu L; Yang Z; Wang H; Zhang Y; Wu W; Singh PK; Wang J; Li F; Li Q
    J Med Chem; 2023 Dec; 66(24):16888-16916. PubMed ID: 38100041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].
    An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y
    Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
    Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.
    Ling X; Liu X; Zhong K; Smith N; Prey J; Li F
    Am J Transl Res; 2015; 7(10):1765-81. PubMed ID: 26692923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.
    Wang J; Liu Z; Zhang D; Liu R; Lin Q; Liu J; Yang Z; Ma Q; Sun D; Zhou X; Jiang G
    Am J Transl Res; 2017; 9(8):3676-3686. PubMed ID: 28861158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.
    Thangaiyan R; Aljahdali IA; Lent-Moore KY; Liao J; Ling X; Li F
    Am J Transl Res; 2021; 13(7):7458-7474. PubMed ID: 34377229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
    Santha S; Ling X; Aljahdali IAM; Rasam SS; Wang X; Liao J; Wang J; Fountzilas C; Li Q; Qu J; Li F
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell models.
    Weng Q; Zhou L; Xia L; Zheng Y; Zhang X; Li F; Li Q
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):527-537. PubMed ID: 31030236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X
    Thummuri D; Khan S; Underwood PW; Zhang P; Wiegand J; Zhang X; Budamagunta V; Sobh A; Tagmount A; Loguinov A; Riner AN; Akki AS; Williamson E; Hromas R; Vulpe CD; Zheng G; Trevino JG; Zhou D
    Mol Cancer Ther; 2022 Jan; 21(1):184-192. PubMed ID: 34667112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
    Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
    Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.